Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients
Alimentary Pharmacology and Therapeutics, 07/01/09
Andriulli A et al. - In decompensated cirrhotic patients, anti-viral therapy with current regimens is feasible and associated with an overall SVR rate of 35.1%. Treatment ought to be pursued among patients who attain an EVR, and maintain a full course and dosage of therapy.
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Zinc and micronutrient combinations to combat gastrointestinal inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/23/09
The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea
Therapeutics and Clinical Risk Management, 10/21/09
Methane and the Gastrointestinal Tract
Digestive Diseases and Sciences, 10/22/09
Article Search
Sponsor


See Latest Articles


